A novel tetrahedral framework nucleic acid‐derived chemodynamic therapy agent for effective glioblastoma treatment
Cell Proliferation · 2025-01 · 58 (1)
DOI: 10.1111/cpr.13736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 24.08.2024. Verfasst von Xiaodie Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Glioblastoma, Nucleic Acids, Hydrogen Peroxide. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Science and Technology Program of Guangzhou, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Chemodynamic therapy (CDT) has garnered significant attention for treating diverse malignant tumours due to its minimally invasive nature, reduced damage to healthy tissues, and potential mitigation of side effects. However, its application in glioblastoma (GBM) is hindered by the diminished capacity of CDT agents to traverse the blood–brain barrier (BBB), inadequate tumour targeting efficiency, and restricted availability of H 2 O 2 within the tumour microenvironment (TME). To address these challenges, we devised a novel CDT agent (Fe@tFNAs‐ANG‐3AT) based on a tetrahedral framework nucleic acids (tFNAs). Fe@tFNAs‐ANG‐3AT was constructed by anchoring iron ions (Fe 3+ ) onto the dual appendages‐modified tFNAs. Specifically, one appendage, Angiopep‐2 (ANG, a penetrating peptide), facilitates Fe@tFNAs‐ANG‐3AT penetration across the BBB and selective targeting of tumour cells. Simultaneously, the second appendage, 3‐Amino‐1,2,4‐triazole (3AT, a H 2 O 2 enzyme inhibitor), augments the H 2 O 2 levels required for effective CDT treatment. Upon tumour cell internalization, the loaded Fe 3+ in Fe@tFNAs‐ANG‐3AT is reduced to Fe 2+ by the overexpressed glutathione (GSH) in the TME, catalysing the generation of cytotoxic hydroxyl radicals (·OH) and inducing tumour cell death via elevated oxidative stress levels within tumour cells. It is anticipated that Fe@tFNAs‐ANG‐3AT holds promise as a transformative treatment strategy for GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- Clinical Research Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- Department of Anesthesiology of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, China.
- Central Laboratory of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, China.
ORCID-Profile: Chao Zhang
Förderung
- the National Natural Science Foundation of China
- Science and Technology Program of Guangzhou
- Guangdong Basic and Applied Basic Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Li, X., Li, L., Fu, X., Huang, S., Wang, Y., Yang, Y., Zhou, S., Zou, Z., Peng, Q., & Zhang, C. (2025). A novel tetrahedral framework nucleic acid‐derived chemodynamic therapy agent for effective glioblastoma treatment. Cell Proliferation, 58(1). https://doi.org/10.1111/cpr.13736
Vancouver
Li X, Li L, Fu X, Huang S, Wang Y, Yang Y, et al. A novel tetrahedral framework nucleic acid‐derived chemodynamic therapy agent for effective glioblastoma treatment. Cell Proliferation. 2025;58(1). doi:10.1111/cpr.13736
BibTeX
@article{Li2025,
author = {Li, Xiaodie and Li, Lei and Fu, Xin and Huang, Shiqian and Wang, Yuhao and Yang, Yuepeng and Zhou, Shuqin and Zou, Zhaowei and Peng, Qing and Zhang, Chao},
title = {A novel tetrahedral framework nucleic acid‐derived chemodynamic therapy agent for effective glioblastoma treatment},
journal = {Cell Proliferation},
year = {2025},
volume = {58},
number = {1},
doi = {10.1111/cpr.13736}
}
EUVIMED